NFJ Investment Group’s AbbVie ABBV Stock Holding History

NFJ Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.5M	Buy	112,839 +5,128	+5%	+$1.14M	0.93%	40
2025 Q4	$24.6M	Sell	107,711 -18,911	-15%	-$4.31M	0.89%	39
2025 Q3	$29.3M	Buy	126,622 +50,980	+67%	+$10.4M	1.01%	34
2025 Q2	$14M	Sell	75,642 -2,354	-3%	-$437K	0.49%	66
2025 Q1	$16.3M	Buy	+77,996	New	+$15.2M	0.55%	60
2022 Q2	–	Sell	-202,278	Closed	-$32.8M	–	314
2022 Q1	$32.8M	Sell	202,278 -277,772	-58%	-$40.3M	0.67%	43
2021 Q4	$65M	Buy	480,050 +256,263	+115%	+$30.3M	1.19%	13
2021 Q3	$24.1M	Buy	223,787 +1,963	+0.9%	+$224K	0.47%	63
2021 Q2	$25M	Buy	221,824 +2,578	+1%	+$290K	0.47%	65
2021 Q1	$23.7M	Buy	+219,246	New	+$23.5M	0.48%	60

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NFJ Investment Group's ABBV Position: Q1 2026 in Review

NFJ Investment Group increased its AbbVie (ABBV) stake by 4.8% in Q1 2026, buying an estimated $1.14M and bringing the position to 112,839 shares worth $24.5M. The position accounts for 0.93% of the portfolio, ranked #40.

NFJ Investment Group first reported a position in ABBV in Q1 2021 and has held it in 10 quarters since. The position peaked at $65M in Q4 2021. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

NFJ Investment Group held 112,839 shares of AbbVie worth $24.5M as of Q1 2026.
NFJ Investment Group bought 5,128 AbbVie shares in Q1 2026, an estimated $1.14M.
AbbVie made up 0.93% of NFJ Investment Group's portfolio in Q1 2026, its #40 holding.
NFJ Investment Group first reported a position in AbbVie in Q1 2021 and has held it in 10 quarters since.
NFJ Investment Group's AbbVie position peaked at $65M in Q4 2021.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on NFJ Investment Group's 13F filing for Q1 2026, filed 13 May 2026.